Premium
Managing care for patients with sinonasal and anterior skull base cancers during the COVID‐19 pandemic
Author(s) -
TurriZai Mario,
Battaglia Paolo,
Karligkiotis Apostolos,
Locatelli Davide,
Castelnuovo Paolo
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26257
Subject(s) - medicine , pandemic , covid-19 , multidisciplinary approach , intensive care medicine , health care , cancer , telemedicine , skull , dissection (medical) , multidisciplinary team , disease , surgery , medical emergency , infectious disease (medical specialty) , nursing , social science , sociology , economics , economic growth
The SARS‐CoV‐2 pandemic has rapidly transformed health care delivery around the globe. Because of the heavy impact of COVID‐19 spread, cancer treatments have necessarily been de‐prioritized, thus exposing patients to increased risk of morbidity and mortality due to delayed care. In this scenario, cancer specialists need to assess critical oncology patients case by case to carefully balance risk vs benefit in treating tumors and preventing SARS‐CoV‐2 infection. Here, we report early insights into how the management of patients with sinonasal and anterior skull base cancer might be affected by the COVID‐19 pandemic. We provide recommendations for preoperative tests, indications for immediate care vs possible delayed treatment, and warnings relating to dural resection and intracranial dissection, given the potential neurotropism of SARS‐CoV2 and practical suggestions for managing cancer care in a period of limited resources. We also postulate some thoughts on the promising role of telemedicine in multidisciplinary case discussions and posttreatment surveillance.